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Display of hepatitis B virus PreS1 peptide on bacteriophage T7 and its potential in gene 
delivery into HepG2 cells. 
 
Abstract 
Hepatitis B is a major public health problem worldwide which may lead to chronic liver 
diseases, cirrhosis and hepatocellular carcinoma. An interaction between hepatitis B virus 
(HBV) envelope protein, particularly the PreS1 region, and a specific cell surface receptor is 
believed to be the initial step of HBV infection through attachment to hepatocytes. In order to 
develop a gene delivery system, bacteriophage T7 was modified genetically to display 
polypeptides of the PreS1 region. A recombinant T7 phage displaying amino acids 60-108 of 
the PreS1 region (PreS1(60-108)) was demonstrated to be most effective in transfecting 
HepG2 cells in a dose- and time-dependant manner. The phage genome was recovered from 
the cell lysate and confirmed by PCR whereas the infectious form of the internalized phage 
was measured by a plaque-forming assay. The internalized phage exhibited the appearance of 
green fluorescent dots when examined by immunofluorescence microscopy. Surface 
modification, particularly by displaying the PreS1(60-108) enhanced phage uptake, resulting 
in more efficient in vitro gene transfer. The ability of the recombinant phage to transfect 
HepG2 cells demonstrates the potential of the phage display system as a gene therapy for 
liver cancer. 
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